Zoll buys Philips temperature biz; Fogarty Institute accepts startup applications;

@FierceMedDev: FDA panel recommends approval of Alcon intraocular lens. More | Follow @FierceMedDev

@EmilyWFierce: Sales of heart devices pump new life into $MDT's Q2 earnings, boost revenues to $4.37B. Story | Follow @EmilyWFierce

> Zoll Medical will acquire Philips' ($PHG) InnerCool temperature management business, including catheter-based endovascular and surface temperature management technologies, for an undisclosed amount. Release

> The Fogarty Institute for Innovation is accepting applications on a search to find one to three more startup devicemakers to mentor, train and provide access to equipment and other entrepreneurs. More

> Ether, a watch-like device that allows an operating room manager to receive real-time data from anesthesia providers, won the first-place prize at a recent wearables hackathon. Read

> A Harvard Clinical Research Institute study found that extending dual antiplatelet therapy for more than a year after coronary stent implantation is highly beneficial for patients. Release

Biotech News

@FierceBiotech: Novartis joins Atlas in launching a CRISPR Cas biotech with a $15M bankroll. Article | Follow @FierceBiotech

@JohnCFierce: FDA orders $CYTR to halt patient enrollment after death of a cancer patient - and they're scrambling to lift hold. Story | Follow @JohnCFierce

@DamianFierce: $ACT's Saunders: looking at a "mid to high teens cut to our R&D spend" after $AGN integration, mostly "low-value programs." | Follow @DamianFierce

> Novartis revs up a promising pharmacoeconomic case for heart failure drug LCZ696. Report

> AstraZeneca toasts to independent living with big plans for its Pfizer-free future. Story

> FDA orders CytRx to halt patient enrollment after death of a cancer patient. Article

Pharma News

@FiercePharma: Actavis' merger cost-cutting isn't Valeant-style. But it's still $1.8B. Story | Follow @FiercePharma

@CarlyHFierce: Valeant and Allergan's wining-and-dining shows docs still hold the script reins. More | Follow @CarlyHFierce

> Has Allergan failure weakened Valeant CEO's M&A hand? Story

> AstraZeneca's anti-Pfizer growth promises? At least one big investor is buying. More

Biotech Research News

> Microbiome research project IDs 'good' bacteria that combat obesity. Article

> Knocking out a pair of genes may help prevent a relapse of leukemia. Story

> Structural modeling at Scripps points to better Ebola drug cocktails. Article

> Cardiovascular investigator pinpoints a new drug target in heart disease. Item

> Brown fat fingers a new target for metabolic disorders, including diabetes. More

Pharma Manufacturing News

> Ranbaxy fights FDA for killing its approval to make generic Nexium. Story

> Apotex recalling blood pressure med made at banned plant in India. Report

> Recipharm picks up two more plants, this time in Portugal. Item

> Bristol-Myers to build $900M biologics plant in Ireland. Story

> Getting more FDA inspectors in China on Hamburg's agenda for trip to China. Article